Mastitis Injection (Cefquinome Sulphate Injection)

Mastitis Injection (Cefquinome Sulphate Injection)

Last updated on

11 Feb 2020

Product added on

21 Jan 2020

We are

looking for distributors

Space Required

200 sq ft

Investment Required

Rs 50 K- Rs 99 K

Brand

BOVISO

Product Description

Mastitis Injection (Cefquinome Sulphate Injection) is an extended spectrum Beta-Lactam antibiotic and member of the Fourth Generation Cephalosporins. It is an Amino Thiazole Cephalosporin which have safe and well tolerated in veterinary medicine.


Composition:
Each vial (Part A) contains: Cefquinome as sulphate equivalent to Cefquinome 750 mg
Part B contains: N-Methyl-2 pyrrolidone 300 mg



Indication:
Mammary Infections: Streptococcal Mastitis, Coliform Mastitis, Staphylococcal Mastitis

Respiratory Infections: Haemorrhagic Septicaemia (H.S.) & Contagious Bovine Pleuro Pneumonia (CBPP), Bronchopneumonia, Bovine Respiratory Diseases (BRD)

Gastro Intestinal Tract Infections: Bacterial diarrhoea or dysentery caused by E.coli, Salmonella, Shigella, Campylobacter, Clostridium etc.

Related Products
GetDistributors.com - An ideal platform for anybody who is looking forward to Appointing or Becoming a Distributor, Franchisee and Sales Agent. GetDistributors.com is an initiative by tradeindia.com © 2025 Infocom Network Private Limited. All rights reserved.